瑞康医药

- 002589

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
瑞康医药(002589) 利润表
单位:万元
报表日期2024-06-302024-03-312023-12-312023-09-302023-06-30
一、营业总收入403,166.52201,875.88803,436.80610,506.25407,993.25
营业收入403,166.52201,875.88803,436.80610,506.25407,993.25
二、营业总成本399,733.66202,323.73824,056.44621,021.73418,399.48
营业成本352,584.17177,562.49720,733.58528,662.65354,676.93
营业税金及附加1,706.99735.104,571.653,726.441,736.27
销售费用19,045.218,988.2843,199.6737,553.3525,936.75
管理费用17,515.269,161.6240,825.9633,488.3421,924.80
财务费用8,334.075,565.8813,264.0216,573.2413,498.31
研发费用547.95310.361,461.561,017.70626.42
资产减值损失----------
公允价值变动收益-----22,889.61-27,741.97-17,937.85
投资收益3,215.02500.3540,882.1641,651.2131,834.90
其中:对联营企业和合营企业的投资收益-----606.82----
汇兑收益----------
三、营业利润4,308.952,638.36-12,663.545,110.416,483.20
加:营业外收入98.2826.21293.30461.54298.74
减:营业外支出388.62223.491,171.522,245.8771.49
其中:非流动资产处置损失----------
四、利润总额4,018.602,441.08-13,541.773,326.086,710.44
减:所得税费用-36.59583.97-16,738.90542.882,551.80
五、净利润4,055.201,857.113,197.122,783.204,158.64
归属于母公司所有者的净利润3,102.531,516.902,031.771,922.013,066.73
少数股东损益952.67340.211,165.35861.191,091.92
六、每股收益
基本每股收益(元/股)0.02060.01000.01350.01280.0204
稀释每股收益(元/股)0.02060.01000.01350.01280.0204
七、其他综合收益----------
八、综合收益总额4,055.201,857.113,197.122,783.204,158.64
归属于母公司所有者的综合收益总额3,102.531,516.902,031.771,922.013,066.73
归属于少数股东的综合收益总额952.67340.211,165.35861.191,091.92
下载全部历史数据到excel中 返回页顶